KC
AGN

Kepos Capital’s Allergan plc AGN Stock Holding History

Kepos Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-26,417
Closed -$4.4M – 442
2018
Q2 		$4.4M Buy
+26,417
New +$4.24M 0.22% 109
2018
Q1 		– Sell
-27,784
Closed -$4.54M – 338
2017
Q4 		$4.54M Buy
27,784
+13,664
+97% +$2.45M 0.41% 51
2017
Q3 		$2.89M Buy
+14,120
New +$3.28M 0.48% 30

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Kepos Capital's AGN Position: Q3 2018 in Review

Kepos Capital sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 26,417 shares — an estimated $4.4M sold.

Kepos Capital first reported a position in AGN in Q3 2017 and held it in 3 quarters. The position peaked at $4.54M in Q4 2017. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Kepos Capital reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • Kepos Capital sold 26,417 Allergan plc shares in Q3 2018, an estimated $4.4M.
  • Kepos Capital first reported a position in Allergan plc in Q3 2017 and held it in 3 quarters.
  • Kepos Capital's Allergan plc position peaked at $4.54M in Q4 2017.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Kepos Capital's 13F filing for Q3 2018, filed 13 Nov 2018.